Skip to results
Modify your search
NARROW
1-11 of 11
Authors: Emily C L Wong
Sort by
Journal Article
Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease
Emily C L Wong and others
Journal of Crohn's and Colitis, Volume 19, Issue 1, January 2025, jjaf006, https://doi.org/10.1093/ecco-jcc/jjaf006
Published: 13 January 2025
Journal Article
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn’s Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial
Emily C L Wong and others
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjae171, https://doi.org/10.1093/ecco-jcc/jjae171
Published: 12 November 2024
Journal Article
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
Sunil Samnani and others
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae151, https://doi.org/10.1093/ecco-jcc/jjae151
Published: 20 September 2024
Journal Article
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis
Neeraj Narula and others
Journal of Crohn's and Colitis, Volume 18, Issue 11, November 2024, Pages 1863–1869, https://doi.org/10.1093/ecco-jcc/jjae092
Published: 13 June 2024
Journal Article
Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY study
Emily C L Wong and others
Journal of Crohn's and Colitis, Volume 17, Issue 7, July 2023, Pages 1114–1121, https://doi.org/10.1093/ecco-jcc/jjad033
Published: 23 February 2023
Journal Article
Beyond the White Pill: Advocating for Racial Diversity in IBD Trials
Emily C L Wong and others
Journal of Crohn's and Colitis, Volume 17, Issue 3, March 2023, Pages 459–461, https://doi.org/10.1093/ecco-jcc/jjac134
Published: 10 September 2022
Journal Article
Categorising Endoscopic Severity of Crohn’s Disease Using the Modified Multiplier SES-CD [MM-SES-CD]
Neeraj Narula and others
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1011–1019, https://doi.org/10.1093/ecco-jcc/jjac018
Published: 03 February 2022
Journal Article
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn’s Disease
Neeraj Narula and others
Journal of Crohn's and Colitis, Volume 16, Issue 4, April 2022, Pages 616–624, https://doi.org/10.1093/ecco-jcc/jjab183
Published: 19 October 2021
Journal Article
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn’s Disease: A Post-hoc Analysis
Neeraj Narula and others
Journal of Crohn's and Colitis, Volume 15, Issue 10, October 2021, Pages 1649–1657, https://doi.org/10.1093/ecco-jcc/jjab045
Published: 06 March 2021
Journal Article
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn’s Disease
Emily C L Wong and others
Journal of Crohn's and Colitis, Volume 15, Issue 7, July 2021, Pages 1114–1119, https://doi.org/10.1093/ecco-jcc/jjaa242
Published: 27 November 2020
Journal Article
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn’s Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials
Neeraj Narula and others
Journal of Crohn's and Colitis, Volume 15, Issue 3, March 2021, Pages 462–470, https://doi.org/10.1093/ecco-jcc/jjaa189
Published: 15 September 2020
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals